Inventor · disambiguated record
Timothy Z. Hoffman
Also filed as: HOFFMAN TIMOTHY · HOFFMAN TIMOTHY Z
11 granted patents·10 pending applications·74 citations·filing 2005–2022
88Inventor score
Top patents by PatentIndex Score
21 records- 0192US7470722B2Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of diseaseKALYPSYS INC·Filed 2005·Granted Dec 30, 2008·25 cites·43 claims
- 0290US9944649B2Compounds and compositions as toll-like receptor 7 agonistsCORTEZ ALEX·Filed 2015·Granted Apr 17, 2018·17 cites·19 claims
- 0387US7381749B2Sulfonamides as inhibitors of histone deacetylase for the treatment of diseaseKALYPSYS INC·Filed 2005·Granted Jun 3, 2008·10 cites·30 claims
- 0484US10973826B2Antibody conjugates comprising toll-like receptor agonistCORTEZ ALEX·Filed 2016·Granted Apr 13, 2021·6 cites·28 claims
- 0584US9315530B2Adsorption of immunopotentiators to insoluble metal saltsSINGH MANMOHAN·Filed 2011·Granted Apr 19, 2016·7 cites·18 claims
- 0680US9365506B2Compounds and compositions as TLR2 agonistsWU TOM YAO-HSIANG·Filed 2014·Granted Jun 14, 2016·5 cites·18 claims
- 0776US8808703B2Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etcWU TOM YAO-HSIANG·Filed 2011·Granted Aug 19, 2014·4 cites·18 claims
- 0865US10844068B2Compounds and compositions as toll-like receptor 7 agonistsNOVARTIS AG·Filed 2019·Granted Nov 24, 2020·0 cites·16 claims
- 0965US2023190751A16-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS InhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1062US2021346387A1Antibody conjugates comprising toll-like receptor agonistNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1154US10407431B2Compounds and compositions as toll-like receptor 7 agonistsNOVARTIS AG·Filed 2018·Granted Sep 10, 2019·0 cites·16 claims
- 1253US10098949B2Adsorption of immunopotentiators to insoluble metal saltsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Oct 16, 2018·0 cites·14 claims
- 1352US11458138B26-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitorsNOVARTIS AG·Filed 2018·Granted Oct 4, 2022·0 cites·14 claims
- 1452US2023348852A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1549US2009105124A1Heterocyclic modulators of tgr5KALYPSYS INC·Filed 2008·Application pending·0 cites
- 1646US2009035306A1Quinazolinone modulators of tgr5KALYPSYS INC·Filed 2007·Application pending·0 cites
- 1745US2020131474A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1844US2007135431A1Inhibitors of histone deacetylase for the treatment of diseaseKALYPSYS INC·Filed 2006·Application pending·0 cites
- 1942US2007027184A1Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of diseaseKALYPSYS INC·Filed 2006·Application pending·0 cites
- 2041US2020164084A1Antibody conjugates comprising toll-like receptor agonist and combination therapiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2138US2008194681A1Novel Inhibitors of Histone Deacetylase for the Treatment of DiseaseKALYPSYS INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →